MMEA
ARKG icon

Main Management ETF Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Main Management ETF Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,429,000
Closed -$62.2M – 148
2024
Q3 		$62.2M Sell
2,429,000
-325,610
-12% -$8.29M 2.95% 9
2024
Q2 		$64.7M Buy
2,754,610
+62,470
+2% +$1.58M 3.23% 12
2024
Q1 		$77.4M Buy
2,692,140
+79,475
+3% +$2.39M 4.09% 11
2023
Q4 		$85.7M Buy
2,612,665
+2,121,160
+432% +$57.7M 5.03% 7
2023
Q3 		$7.8M Buy
491,505
+222,325
+83% +$7.27M 0.55% 21
2023
Q2 		$9.18M Buy
269,180
+21,930
+9% +$689K 0.66% 21
2023
Q1 		$7.43M Buy
247,250
+49,710
+25% +$1.54M 0.63% 23
2022
Q4 		$5.58M Buy
197,540
+9,545
+5% +$303K 0.52% 20
2022
Q3 		$6.18M Buy
187,995
+3,735
+2% +$137K 0.71% 19
2022
Q2 		$5.8M Buy
184,260
+40,935
+29% +$1.43M 0.64% 19
2022
Q1 		$6.58M Buy
143,325
+49,825
+53% +$2.38M 0.61% 20
2021
Q4 		$5.73M Buy
93,500
+12,250
+15% +$847K 0.5% 22
2021
Q3 		$6.07M Buy
81,250
+3,750
+5% +$315K 0.61% 22
2021
Q2 		$7.17M Buy
77,500
+7,010
+10% +$596K 0.75% 19
2021
Q1 		$6.25M Buy
+70,490
New +$6.99M 0.74% 18

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Main Management ETF Advisors's ARKG Position: Q4 2024 in Review

Main Management ETF Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 2,429,000 shares — an estimated $62.2M sold.

Main Management ETF Advisors first reported a position in ARKG in Q1 2021 and held it in 15 quarters. The position peaked at $85.7M in Q4 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Main Management ETF Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Main Management ETF Advisors sold 2,429,000 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $62.2M.
  • Main Management ETF Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 15 quarters.
  • Main Management ETF Advisors's ARK Genomic Revolution ETF position peaked at $85.7M in Q4 2023.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Main Management ETF Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.